Viewing Study NCT00887757


Ignite Creation Date: 2025-12-24 @ 6:37 PM
Ignite Modification Date: 2025-12-30 @ 3:34 AM
Study NCT ID: NCT00887757
Status: COMPLETED
Last Update Posted: 2017-11-21
First Post: 2009-04-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module